{
    "title": "GSK to buy Sierra Oncology amid pressure to boost drug pipeline",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10714173/GSK-buy-Sierra-Oncology-1-9-bln-boost-blood-cancer-ops.html",
    "date": "2022-04-13",
    "keywords": [
        "cancer",
        "drug",
        "business",
        "sierra",
        "gsk",
        "grover",
        "developer",
        "elliott",
        "company",
        "year",
        "price",
        "momelotinib",
        "myelofibrosis",
        "quarter",
        "trial",
        "blood",
        "acquisition",
        "wednesday",
        "deal",
        "move",
        "pressure",
        "shareholder",
        "pipeline",
        "stake",
        "consumer",
        "healthcare",
        "toothpaste",
        "july",
        "share",
        "stock",
        "cash",
        "premium",
        "companys",
        "closing",
        "gmt",
        "tag",
        "doesnt",
        "look",
        "note",
        "type",
        "bone",
        "marrow",
        "approval",
        "latestage",
        "january",
        "disease",
        "cut",
        "dependence",
        "key",
        "risk",
        "execution",
        "launch",
        "number",
        "space",
        "study",
        "treatment",
        "form",
        "myeloma",
        "overlap",
        "customer",
        "base",
        "blenrep",
        "haematology",
        "officer",
        "oncology",
        "exclusivity",
        "dolutegravir",
        "end",
        "worth",
        "appetite",
        "autoimmune",
        "yadarisa",
        "shabong",
        "bengaluru",
        "editing",
        "josephine",
        "mason",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}